Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019)
Aquestive Therapeutics' (AQST) quarterly Amortizatization of Intangibles came in at $36000.0 in Q3 2019, up 9.09% year-on-year from $33000.0 in Q3 2018, and little changed quarter-over-quarter from $36000.0 in Q2 2019.
Aquestive Therapeutics (AQST) Amortizatization of Intangibles (2017 - 2019) Analysis & Trends
Aquestive Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $36000.0 for Q3 2019.
- On a quarterly basis, Amortizatization of Intangibles rose 9.09% year-over-year to $36000.0 in Q3 2019; TTM through Sep 2019 was $134000.0, a 0.0% change from a year earlier, with the FY2018 full-year figure at $130000.0, up 6.56% from the prior year.
- Amortizatization of Intangibles was little changed at $36000.0 in Q3 2019 per AQST's latest filing, from $36000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $36000.0 in Q2 2019 and bottomed at $28000.0 in Q4 2018.
- The 3-year median for Amortizatization of Intangibles is $34000.0 (2018), against an average of $33222.2.
- Across the five-year window, Amortizatization of Intangibles fell 12.5% in 2018 and rose 9.09% in 2019, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $32000.0 in 2017, then decreased by 12.5% to $28000.0 in 2018, then advanced by 28.57% to $36000.0 in 2019.
- Per Business Quant, the three latest AQST Amortizatization of Intangibles figures stand at $36000.0 (Q3 2019), $36000.0 (Q2 2019), and $34000.0 (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Aquestive Therapeutics | 456.72 Mn | 456.72 Mn | 13.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 36,000.00 |
| Sep 30, 2019 | 36,000.00 |
| Jun 30, 2019 | 36,000.00 |
| Jun 30, 2019 | 36,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | 28,000.00 |
| Dec 31, 2018 | 28,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Sep 30, 2018 | 33,000.00 |
| Jun 30, 2018 | 35,000.00 |
| Jun 30, 2018 | 35,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Mar 31, 2018 | 34,000.00 |
| Dec 31, 2017 | 32,000.00 |
| Dec 31, 2017 | 32,000.00 |
| Sep 30, 2017 | 31,000.00 |
| Sep 30, 2017 | 31,000.00 |